Articles On Adherium (ASX:ADR)

Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million   The...

The long and short of 2022 is that it was a frustrating period for the Australian biotech sector but one with its fair share of rewards as the sector’s exponents furthered worthy drugs, diagnostics, devices and doodahs. For the sixth year,...

ASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11 sectors finish lower China could reopen next year with ‘seismic’ implications for the rest of the world   The local bourse has dropped for...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX 200 ends 0.7% higher Small cap index flat NYM, BEZ, CPH best in show    Lithium keeps finding another gear. The analysts at Citi lifted target forecasts after the Marrickville government and others besides prepare to throw some suppor...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 halves gains on the run home  Small cap index closes about 0.7% higher Tinkler takes more Jameson, shares jumps 50%   Up strongly this morning following some epic 90’s style US leads on Friday… …the benchmark ASX200 is giving it...

ASX 200 closes with -1.8% loss Small cap index down -1.2% Up way more than 100% is Norfolk Minerals, the real NFL   Everyone in this part of the world seems pretty upset by the US Federal Reserve Chairman Jerome Powell – more so than the...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 limps home with 0.1% gain Small cap index drags itself almost to close flat WR1 cops speeding ticket after 57% surge   On Wall Street, the S&P 500 lost 0.5%, Dow Jones Industrial Average slipped 0.2 %.and the Nasdaq Composite...

ASX closes out the day lower by about 0.74% Online matchmakers Love Group goes on a bodice-busting 39% jag Woman tries to stop eviction with a swarm of bees. No, really…   Aussie markets are set to meander to a close around 0.74% down for...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

ASX 200 ends 0.3% higher Small caps ahead 0.4% Dr Oliver says go climb the wall of worry, Dolorean does exactly that, up +30%   The ASX 200 and the Emerging Companies (XEC) index rose 0.3% and 0.4% respectively on Wednesday. The insurer M...

ASX slides early and long on Monday Small cap index crashes -2.3% Besra Gold (ASX:BEZ) just tripled its own sense of self   We’re all in the same boat on Monday, floating aimlessly about the big blue of the Pacific amidst inflation and it...

Aussie markets end Friday on a -0.80% disappointment US signals new cannabis laws, good news for Aussie producers Zelensky the hot tip to win a rare mid-war Nobel Peace Prize   The ASX has dribbled  it’s way towards Friday’s -0.80% close,...

Benchmark finishes up after fierce struggle for buoyancy Absolutely no one shocked to learn Star’s worn out its welcome in QLD A solid arvo by little league miners was a well-timed boost It’s been a somewhat indecisive day for Aussie mark...

Benchmark spikes, falls, recovers, trips again, stays down.   Small caps just fall Delta Drones, Danakali rise   Choppy, dicey, angsty trade on Monday. Low volumes and high volatility. It’s almost like the markets themselves are in fact s...

ASX 200 down 0.5% Small caps  crash about 1.1% OXR up 50% on some quality HR     And that’s how you say Wednesday was merde in French. Let’s do some good news first. Aussie retail sales climbed for an eighth consecutive month in August,...

Benchmark set to end the day down about 2.0% Geopolitics and overseas rate-raising spree weigh heavily A couple of late bolters bring some small comfort, but really…  Another Friday, and another entirely sub-par experience for anyone watc...

The ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40% on takeover talk   The benchmark ASX 200 is flat as on Monday. The ASX Emerging Companies (XEC) index has lost 1.3%. REITs and Gold are h...

Respiratory eHealth company Adherium (ADR) is set to raise $13.5 million through a private share placementUnder the placement, the company will issue 2.7 billion new shares at 0.5 cents per share under three tranches, and it also plans to l...

Adherium (ADR) enters into a trading halt pending a capital raise announcementThe company is planning to launch a placement to sophisticated and professional investors but did not give details on to how much it was looking to raise Trading...

The ASX 200 falls 2.6%  after Wall St rout  Small caps recover manfully to be just 1% lower  AQC is turning out be a hell of a ride   Firstly, the Benchmark ASX 200 is down about 2.5% on Wednesday. It’s a fair whack, but hardly worse tha...

Respiratory medical devices business Adherium was out with a steeply discounted $13.5 million placement on Thursday morning to spend on product development, marketing and the like.

The ASX will open higher on Friday Fed’s Powell warns of more rate hikes ECB makes a historic 75bp rate increase Local shares are set to open higher today. At 8am AEST, the ASX 200 September futures contract is pointing up by 0.10%. Thous...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Local markets follow Wall St ‘hopetimism’ lower Small caps smashed, down circa 3% Pot stock CAU delivers ASX first ever pot stock profit The Benchmark is down 1.95% and the small caps index is down 2.7% after climbing late in the session...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Adherium (ASX: ADR) has announced that it has received US FDA clearance to market application connecting GSK’s Ellipta inhaler users with its new Hailie sensor with physiological parameters for monitoring Asthma and COPD medication...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Respiratory eHealth company Adherium (ADR) signs its first UK distribution deal with Helicon Health to sell the Hailie sensor range and cloud data services Helicon Health is a medical technology company that delivers technological innovati...

Benchmark and small cap index down hard Life on the indices can be hard, unless your in energy, possibly materials Pearl Gull Iron is an island, literally and figuratively   The ASX200 and its emerging companies sidekick have retreated in...

Respiratory eHealth company Adherium (ASX:ADR) has announced the appointment of Tara Creaven-Capasso as its vice president of quality, regulatory and clinical affairs.

Aussie small cap index falls 1.4% The ASX200 down 1.65% Thursday is Arafura Day!   Down less than 2% and I think we can call that a win. No one likes the sight of blood and after the major Wall Street indices shed more than 3.5% a piece,...

XEC down 2.7% XJO down 1.8% Dateline Resources (ASX: DTR) hits the trifecta    Markets across Asia are mostly heading downtown following Wall Street’s latest sell-off.  Tech names are in the biggest mess thanks to the latest inspired chao...

Respiratory eHealth, remote monitoring and data management solutions company Adherium (ASX:ADR) has announced the release of the latest Hailie platform integration tools.

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Digital health company Adherium (ASX:ADR) has appointed Francis White as the vice president of global business development based in the UK.

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Respiratory eHealth company Adherium (ASX:ADR) has submitted to the US FDA for 510(k) clearance to connect Ellipta inhaler users with its new Hailie sensor.

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

The ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader index which is down by 0.37%. Visioneering Technologies (ASX:VTI) has enrolled the first patient in its landmark international clinical trial...

Despite closing lower today, the ASX finished 2021 over 13% where it begun. This compares to a loss of just over 1% in 2020 but a gain of over 20% in 2019. But the ASX did retreat today, snapping a winning streak of 6 trading days and all s...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...